Hormone Replacement Therapy Doubles Risk of Breast Cancer

Women Warned to Stop HRT Drugs

Drug companies can no longer deny the science: Breast cancer risk is doubled for women who take conventional Hormone Replacement Therapy (HRT) drugs.

That's the conclusion of a new study conducted at Georgetown University's Lombardi Comprehensive Cancer Center. There, researchers discovered that even though HRT drugs double a woman's risk of breast cancer, that risk drops rapidly once she stops using the HRT drugs.

Notably, these increased cancer risk findings only apply to synthetic HRT drugs produced by Big Pharma. They do not apply to bio-identical hormones offered by compounding pharmacies and naturopathic physicians.

But bio-identical hormones are under assault by the FDA, which recently tried to outlaw them by threatening compounding pharmacies that were selling them as an alternative to conventional HRT drugs. Care to guess who was behind the FDA's effort to crush the alternative hormones market? Wyeth, of course: The maker of Prempro, the conventional HRT drug. Wyeth petitioned the FDA to go after bio-identical hormones, and the FDA quickly obliged.

Read about the FDA's threatening letter to compounding pharmacies here: http://www.naturalnews.com/023860.html

But it gets even more interesting: Wyeth was also recently caught directing the ghostwriting of medical journal articles even while refusing to disclose its own role in creating those articles. An investigation by Sen. Charles Grassley's office revealed damning documentation showing the drug company was engaged in highly unethical and deceptive practices regarding medical journal articles. Read the details on that here: http://www.naturalnews.com/News_000614_...

Can you guess what drug those ghost-written medical journal articles were promoting? Prempro, of course, the HRT drug!

The HRT conspiracy unveiled

So let's put the pieces of this puzzle together. We have a drug company, Wyeth, that sells a synthetic HRT drug known to double the risk of breast cancer. But instead of pulling the drug off the market, Wyeth files a petition with the FDA to eliminate the competition (bio-identical hormones).